BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has executed a global licensing collaboration agreement with Novartis to develop and commercialize gene regulation therapies to address three neurodevelopmental targets, including autism spectrum disorder (ASD) and other neurodevelopmental disorders. The collaboration will leverage Sangamos propriety genome regulation technology, zinc finger protein transcription factors (ZFP-TFs), to aim to upregulate the expression of key genes involved in neurodevelopmental disorders.
At Sangamo, we believe that we can engineer zinc finger proteins to address virtually any genomic target, and we are building a broad pipeline of wholly owned and partnered programs with the goal to bring our genomic medicines to patients. In the case of the central nervous system, there are potentially hundreds of neurological disease gene targets that may be addressable by our zinc finger platform, said Sandy Macrae, CEO of Sangamo. Partnering Sangamos proprietary technology with Novartis deep experience in neuroscience drug development is a powerful combination which expands Sangamos pipeline and allows us to tackle challenging neurodevelopmental conditions. Our goal in this collaboration is to create genomic medicines for patients with neurodevelopmental disorders, such as autism, that can potentially alter the natural history of these complex lifelong disorders.
This collaboration with Sangamo is part of our commitment to pioneering the next generation of neurodevelopmental treatments, said Jay Bradner, President of the Novartis Institutes for BioMedical Research. The goal is to create new gene regulation therapies that act at the genomic level, moving us beyond the symptom focused treatments of today and toward therapies that can address some of the most challenging neurodevelopmental disorders.
Sangamos ZFP-TF genome regulation technology, which is currently delivered with adeno-associated viruses (AAVs), functions at the DNA level to selectively repress or activate the expression of specific genes to achieve a desired therapeutic effect. The collaboration will leverage ZFP-TFs engineered by Sangamo scientists in an effort to upregulate, or activate, the expression of genes that are inadequately expressed in individuals with certain types of neurodevelopmental disorders.
Under the terms of the agreement, over a three-year collaboration period, Novartis has exclusive rights to ZFP-TFs targeted to three undisclosed genes which are associated with neurodevelopmental disorders, including ASD and intellectual disability. Novartis also has the option to license Sangamos proprietary AAVs. Sangamo is responsible for certain research and associated manufacturing activities, all of which will be funded by Novartis, and Novartis assumes responsibility for additional research activities, investigational new drug-enabling studies, clinical development, related regulatory interactions, manufacturing and global commercialization.
Under the collaboration agreement, Novartis will pay Sangamo a $75 million upfront license fee payment within thirty days. In addition, Sangamo is eligible to earn up to $720 million in other development and commercial milestone payments, including up to $420 million in development milestones and up to $300 million in commercial milestones. Sangamo is also eligible to receive from Novartis tiered high single-digit to sub-teen double-digit royalties on potential net commercial sales of products arising from the collaboration.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit http://www.sangamo.com.
Forward Looking Statements
This press release contains forward-looking statements regarding Sangamo's current expectations. These forward-looking statements include, without limitation, statements relating to the potential to develop, obtain regulatory approvals for and commercialize safe and effective therapies to treat neurodevelopmental disorders and the timing and availability of such therapies, the potential for Sangamo to receive upfront licensing fees and earn milestone payments and royalties under the Novartis collaboration and the timing of such fees, payments and royalties, the potential to use ZFP-TF technology to upregulate specific genes involved with neurodevelopmental disorders, the therapeutic potential of Sangamos zinc finger platform and other statements that are not historical fact. These statements are not guarantees of future performance and are subject to risks and uncertainties that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to: the evolving COVID-19 pandemic and its impact on the global business environment, healthcare systems and the business and operations of Sangamo and Novartis; the research and development process; the unpredictable regulatory approval process for product candidates across multiple regulatory authorities; the manufacturing of products and product candidates; the commercialization of approved products; the potential for technological developments that obviate technologies used by Sangamo and Novartis; the potential for Novartis to breach or terminate the collaboration agreement; and the potential for Sangamo to fail to realize its expected benefits of the Novartis collaboration. There can be no assurance that Sangamo will earn any milestone or royalty payments under the Novartis collaboration or obtain regulatory approvals for product candidates arising from these collaborations. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in Sangamo's and Novartis operations and business environments. These risks and uncertainties are described more fully in Sangamo's filings with the U.S. Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and Annual Report on Form 10-K for the year ended December 31, 2019. Forward-looking statements contained in this announcement are made as of this date, and Sangamo undertakes no duty to update such information except as required under applicable law.
See the article here:
Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders - Business Wire
- ENCODE: Encyclopedia Of DNA Elements - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- 07.05.2010 - The Human Genome [ Coast To Coast AM ] - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- NOVA scienceNOW : 51 - Public Genomes, Algae Fuel, Mystery of the Gakkel Ridge, Yoky Matsuoka - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Vincent T. - Genome (Club Remix) - [Preview] - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Comparing The Human And Chimpanzee Genomes - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Whole Genome Sequencing and Its Impact on Clinical Care - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Carlos Bustamante -- "Reconstructing the Great Human Diasporas from Genome Variation Data" - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- 3 Sad Surprises: The Human Genome Project - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- The RFW interviews Genome - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Science Bulletins: Scientists Peer Inside "Superbug" Genome - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Genome : Live @ Smu's : June 3 2012 - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Inoki Genome Federation - Genome 19 - 04 02 2012 - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- THE HUMAN GENOME MUSIC PROJECT - CHROMOSOME 1 - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Genomic Medicine - Bruce Korf (2012) - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Human Genome's 'Blockbuster' Potential Undervalued in Bid GSK vs HGSI - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Announcing the Completion of the First Survey of the Entire Human Genome at the White House - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- DNA analysis Part I. Genomic Sequencing - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- The Genome Question: Moore vs. Jevons with Bud Mishra - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Genome-Wide Association Studies - Karen Mohlke (2012) - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- New human genome research aids understanding of disease [Last Updated On: September 8th, 2012] [Originally Added On: September 8th, 2012]
- UNC Lineberger scientists lead definition of key lung cancer genome [Last Updated On: September 10th, 2012] [Originally Added On: September 10th, 2012]
- Illumina Announces Expedited Individual Genome Sequencing Service (IGS) [Last Updated On: September 11th, 2012] [Originally Added On: September 11th, 2012]
- Genome research given a boost with opening of bioscience facility [Last Updated On: September 11th, 2012] [Originally Added On: September 11th, 2012]
- Re-Imagining Our Genes: ENCODE Project Reveals Genome as an Information Processing System [Last Updated On: September 11th, 2012] [Originally Added On: September 11th, 2012]
- Illumina unveils upgraded genome sequence service [Last Updated On: September 12th, 2012] [Originally Added On: September 12th, 2012]
- US Personalized Cancer Genome Sequencing Market [Last Updated On: September 18th, 2012] [Originally Added On: September 18th, 2012]
- Yale maps “uncharted” genome regions [Last Updated On: September 18th, 2012] [Originally Added On: September 18th, 2012]
- Research and Markets: US Personalized Cancer Genome Sequencing Market [Last Updated On: September 19th, 2012] [Originally Added On: September 19th, 2012]
- 3Qs: New clues to unlocking the genome [Last Updated On: September 19th, 2012] [Originally Added On: September 19th, 2012]
- Oyster Genome Pries Open Mollusk Evolutionary Shell [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Bangladeshi scientist decodes genome of deadly fungus [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Oyster genome uncover the stress adaptation and complexity of shell formation [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- The oyster genome reveals stress adaptation and complexity of shell formation [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Diseases of aging map to a few 'hotspots' on the human genome [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- GnuBIO Awarded $4.5 Million in Funding from the National Human Genome Research Institute to Develop Lower Cost Genome ... [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Oyster genome mystery unravelled [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Devangshu Datta: What's in a genome [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Pacific Oyster Genome Shows Stress Adaptation And Complexity Of Shell Formation [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- UNC Lineberger scientists lead cancer genome analysis of breast cancer [Last Updated On: September 24th, 2012] [Originally Added On: September 24th, 2012]
- Encoding the human genome [Last Updated On: September 24th, 2012] [Originally Added On: September 24th, 2012]
- Cancer genome analysis of breast cancer: Team identifies genetic causes and similarity to ovarian cancer [Last Updated On: September 24th, 2012] [Originally Added On: September 24th, 2012]
- Fungus genome map paves way for 'Snow White' jute variety [Last Updated On: September 24th, 2012] [Originally Added On: September 24th, 2012]
- New online, open access journal focuses on microbial genome announcements [Last Updated On: September 25th, 2012] [Originally Added On: September 25th, 2012]
- By Simply Sharing, Doctors Could Unlock the Genome's Potential [Last Updated On: September 25th, 2012] [Originally Added On: September 25th, 2012]
- Forget the Cloud—Knome Offers Genome Analysis in a Box [Last Updated On: September 28th, 2012] [Originally Added On: September 28th, 2012]
- BGI@CHOP Joint Genome Center to Offer Clinical Next-Generation Sequencing Services [Last Updated On: September 28th, 2012] [Originally Added On: September 28th, 2012]
- Holy Bat Virus! Genome Hints At Origin Of SARS-Like Virus [Last Updated On: September 29th, 2012] [Originally Added On: September 29th, 2012]
- Community Fundraising Effort Helps Researchers Sequence Parrot Genome [Last Updated On: September 29th, 2012] [Originally Added On: September 29th, 2012]
- UMass Med professors are sleuths of the genome [Last Updated On: September 30th, 2012] [Originally Added On: September 30th, 2012]
- Knome Introduces the knoSYS™100; First Plug-and-Play Human Genome Interpretation System [Last Updated On: September 30th, 2012] [Originally Added On: September 30th, 2012]
- First large scale trial of whole-genome cancer testing for clinical decision-making reported [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- Should You Get Your Genome Mapped? [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- Surprising differences between apples and pears [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- 50-Hour Whole Genome Sequencing Provides Rapid Diagnosis for Children With Genetic Disorders [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- A map of rice genome variation reveals the origin of cultivated rice [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Genome analysis promises hope for breast cancer patients [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Genome Alberta Welcomes Alberta Minister of Enterprise and Advanced Education, Stephen Khan and Federal Minister of ... [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Fifty-hour whole genome sequencing provides rapid diagnosis for children with genetic disorders [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Will Low-Cost Genome Sequencing Open 'Pandora's Box'? [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Genome testing could help individualize treatments [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Would you get your genome tested? [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- The Genome — a Pandora's Box? [Last Updated On: October 4th, 2012] [Originally Added On: October 4th, 2012]
- Fast genome test could help sick newborns [Last Updated On: October 4th, 2012] [Originally Added On: October 4th, 2012]
- In-Depth Genome Analysis Moves Toward The Hospital Bed [Last Updated On: October 5th, 2012] [Originally Added On: October 5th, 2012]
- Your Verdict On Getting A Genome Test? Bring It On [Last Updated On: October 6th, 2012] [Originally Added On: October 6th, 2012]
- Genome-wide study identifies 8 new susceptibility loci for atopic dermatitis [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- Genome-wide study identifies eight new susceptibility loci for atopic dermatitis [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- Genome interpreter vies for place in clinical market [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- The $1,000 Genome: A Bait and Switch? [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- Mount Sinai School of Medicine Offers First-Ever Course with Whole Genome Sequencing [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- First whole genome sequencing of multiple pancreatic cancer patients has been outlined [Last Updated On: October 11th, 2012] [Originally Added On: October 11th, 2012]
- Cheap genome sequences demand new rules on privacy [Last Updated On: October 11th, 2012] [Originally Added On: October 11th, 2012]
- UConn Gets Grant For Genome Research [Last Updated On: October 11th, 2012] [Originally Added On: October 11th, 2012]
- Inconsistent Genome Privacy Laws Need Toughening, Panel Says [Last Updated On: October 12th, 2012] [Originally Added On: October 12th, 2012]
- US panel calls for stronger privacy for genome data [Last Updated On: October 12th, 2012] [Originally Added On: October 12th, 2012]
- Genome Canada Board Appoints New Chair [Last Updated On: October 12th, 2012] [Originally Added On: October 12th, 2012]
- The $1,000 Genome Is Almost Here- Are We Ready? [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Global genome effort seeks genetic roots of disease [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Massive encyclopedia helps explain how the human genome works [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Genome evolution and carbon dioxide dynamics [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]